Regeneron Pharmaceuticals (REGN) News Headlines

▮ More

Date

Headline

5/16/2019 7:08:58 AM Regeneron Pharma, Sanofi Say Positive Updated Data For Libtayo To Be Shared At ASCO Annual Meeting

5/7/2019 9:21:59 AM Regeneron & Sanofi: Dupixent Approved For Severe Asthma Indication In EU

5/7/2019 9:06:57 AM Regeneron And Sanofi Announce That EC Approve New Indication For Dupixent In Asthma

5/7/2019 7:33:46 AM Regeneron Pharmaceuticals Q1 19 Earnings Conference Call At 8:30 AM ET

5/7/2019 6:37:34 AM Regeneron Pharmaceuticals Q1 adjusted earnings Miss Estimates

5/7/2019 6:32:20 AM Regeneron Q1 GAAP EPS $3.99 And Non-GAAP EPS $4.45

4/29/2019 12:52:49 AM Sanofi: FDA Approves Praluent To Prevent Heart Attack, Stroke, Unstable Angina

4/26/2019 3:15:22 AM Biotech Stocks Facing FDA Decision In May 2019

4/8/2019 7:21:56 AM Regeneron To Invest $800 Mln In Alnylam; To Jointly Develop RNAi Therapeutics

4/8/2019 7:01:41 AM Regeneron And Alnylam Collaborate To Discover, Develop And Commercialize New RNAi Therapeutics

3/26/2019 7:16:18 AM Biotech Stocks Facing FDA Decision In April

3/13/2019 7:01:16 AM Regeneron And Sanofi To Present New Praluent Data At ACC.19

3/8/2019 1:06:22 AM Regeneron And Sanofi Say FDA Accept For Priority Review SBLA For Dupixent

3/8/2019 1:02:12 AM Regeneron And Sanofi : FDA Accept For Priority Review SBLA For Dupixent

3/1/2019 8:43:22 AM Regeneron Says CHMP Recommends Approval Of Dupixent For Asthma Indication

3/1/2019 8:37:48 AM Regeneron And Sanofi Say CHMP Recommends Approval Of Dupixent For Asthma Indication

3/1/2019 7:00:34 AM Regeneron, Sanofi To Present Diverse Set Of Clinical And Real-world Data At 2019 AAD Annual Meeting

2/26/2019 10:51:26 PM Biotech Stocks Facing FDA Decision In March

2/25/2019 5:27:36 PM Regeneron, Sanofi Says Disagree With Verdict Upholding Three Of Five Amgen U.S. Patent Claims On PCSK9 Antibodies

2/25/2019 5:13:40 PM Amgen: Delaware Jury Upholds Validity Of Two Patents Related To PCSK9 Antibodies